Social Change Open Access Articles
Social change is the modification in the social request of a general public. Changes in social organizations, nature, social relations or social practices are remembered for social change. Social change alludes to the social advancement or sociocultural development. Social change might be driven by social, strict, monetary, logical or innovative powers. Two kinds of sources are there for social change. One is arbitrary or one of a kind factors, for example, atmosphere, climate, or the nearness of explicit gatherings of individuals. Another is orderly factors. Assume, fruitful advancement has general necessities, similar to steady and adaptable government, free and accessible assets, and a differing social association of society. In this way, all in all, social change is generally a mix of precise factors alongside some arbitrary or exceptional components. Open access to the logical writing implies the evacuation of obstructions (counting value hindrances) from getting to academic work. There are two equal “roads” towards open access:
Open Access articles and self-filing.
Open Access articles are promptly, uninhibitedly accessible on their Web website, a
model for the most part subsidized by charges paid by the writer (ordinarily through an examination award). The option for a specialist is “self-archiving” (i.e., to distribute in a conventional diary, where just endorsers have quick access, however to make the article accessible on their own and additionally institutional Web locales (counting purported stores or chronicles)), which is a training permitted by numerous academic articles.
High Impact List of Articles
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
Quality data collection: paying attention to the details
Julie Pepe, Christina Jackson
Commentary: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis
Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 9
Acknowledgements: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
-
Certolizumab pegol in the treatment of Crohns disease: evidence from the PRECiSE clinical trial program
Ian C Lawrance
Review Article: Clinical Investigation
Relevant Topics in Clinical